Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Menard

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
British Journal of Cancer|August 9, 2012
Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment responseJ W Thoms, A Dal Pra, P H Anborgh, et al.
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|January 1, 1992
Orthodontics as a risk factor for temporomandibular disorders (TMD). IIC R Kremenak, D D Kinser, T J Melcher, et al.
Science (New York, N.Y.)|July 18, 2020
Autoreactivity in naïve human fetal B cells is associated with commensal bacteria recognitionJeff W Chen, Tyler A Rice, Jason M Bannock, et al.
Genome Research|September 9, 2024
Differences in activity and stability drive transposable element variation in tropical and temperate maizeShujun Ou, Armin Scheben, Tyler Collins, et al.
Frontiers in Immunology|July 23, 2021
The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's SyndromeGwenny M Verstappen, Lu Gao, Sarah Pringle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2025
A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087)G Morton, E Vigneault, M Barkati, et al.
Frontiers in Immunology|August 21, 2018
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung CancerNataly Manjarrez-Orduño, Laurence C Menard, Selena Kansal, et al.
JCI Insight|October 5, 2016
B cells from African American lupus patients exhibit an activated phenotypeLaurence C Menard, Sium Habte, Waldemar Gonsiorek, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
British Journal of Cancer|August 9, 2012
Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment responseJ W Thoms, A Dal Pra, P H Anborgh, et al.
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|January 1, 1992
Orthodontics as a risk factor for temporomandibular disorders (TMD). IIC R Kremenak, D D Kinser, T J Melcher, et al.
Science (New York, N.Y.)|July 18, 2020
Autoreactivity in naïve human fetal B cells is associated with commensal bacteria recognitionJeff W Chen, Tyler A Rice, Jason M Bannock, et al.
Genome Research|September 9, 2024
Differences in activity and stability drive transposable element variation in tropical and temperate maizeShujun Ou, Armin Scheben, Tyler Collins, et al.
Frontiers in Immunology|July 23, 2021
The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's SyndromeGwenny M Verstappen, Lu Gao, Sarah Pringle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2025
A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087)G Morton, E Vigneault, M Barkati, et al.
Frontiers in Immunology|August 21, 2018
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung CancerNataly Manjarrez-Orduño, Laurence C Menard, Selena Kansal, et al.
JCI Insight|October 5, 2016
B cells from African American lupus patients exhibit an activated phenotypeLaurence C Menard, Sium Habte, Waldemar Gonsiorek, et al.
Pageof 7